These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 10658248

  • 21. Multi-institutional validation of a symptom based classification for renal cell carcinoma.
    Patard JJ, Leray E, Cindolo L, Ficarra V, Rodriguez A, De La Taille A, Tostain J, Artibani W, Abbou CC, Guillé F, Chopin DK, Lobel B.
    J Urol; 2004 Sep; 172(3):858-62. PubMed ID: 15310983
    [Abstract] [Full Text] [Related]

  • 22. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, Pea M, Artibani W.
    Cancer; 2005 Jan 01; 103(1):68-75. PubMed ID: 15573369
    [Abstract] [Full Text] [Related]

  • 23. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV.
    Eur Urol; 2005 Oct 01; 48(4):593-600. PubMed ID: 15964127
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S, Brookman-Amissah S, Roigas J, Kendel F, Hoschke B, May M.
    Scand J Urol Nephrol; 2008 Oct 01; 42(6):507-13. PubMed ID: 19031267
    [Abstract] [Full Text] [Related]

  • 28. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2002 Jul 01; 168(1):56-60. PubMed ID: 12050492
    [Abstract] [Full Text] [Related]

  • 29. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.
    Cancer; 2008 Aug 01; 113(3):477-83. PubMed ID: 18484589
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of thrombocytosis in renal cell carcinoma.
    Bensalah K, Leray E, Fergelot P, Rioux-Leclercq N, Tostain J, Guillé F, Patard JJ.
    J Urol; 2006 Mar 01; 175(3 Pt 1):859-63. PubMed ID: 16469566
    [Abstract] [Full Text] [Related]

  • 31. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG.
    J Urol; 2007 Nov 01; 178(5):1878-82. PubMed ID: 17868733
    [Abstract] [Full Text] [Related]

  • 32. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug 01; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 33. [Correlation between the mode of presentation of renal tumors and patient survival].
    Patard JJ, Bensalah K, Vincendeau S, Rioux-Leclerq N, Guillé F, Lobel B.
    Prog Urol; 2003 Feb 01; 13(1):23-8. PubMed ID: 12703350
    [Abstract] [Full Text] [Related]

  • 34. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
    Fiori E, De Cesare A, Galati G, Bononi M, D'Andrea N, Barbarosos A, Izzo L, Bolognese A.
    J Exp Clin Cancer Res; 2002 Jun 01; 21(2):229-32. PubMed ID: 12148583
    [Abstract] [Full Text] [Related]

  • 35. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
    Jeong IG, Jeong CW, Hong SK, Kwak C, Lee E, Lee SE.
    Urology; 2006 Apr 01; 67(4):709-12. PubMed ID: 16566981
    [Abstract] [Full Text] [Related]

  • 36. Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
    Nakayama K, Tannir NM, Liu P, Wathen JK, Cheng YC, Champlin RE, Ueno NT.
    Biol Blood Marrow Transplant; 2007 Aug 01; 13(8):975-85. PubMed ID: 17640602
    [Abstract] [Full Text] [Related]

  • 37. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, Moch H.
    Am J Surg Pathol; 2008 Dec 01; 32(12):1822-34. PubMed ID: 18813125
    [Abstract] [Full Text] [Related]

  • 38. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
    Aaltomaa S, Lipponen P, Kärjä V, Lundstedt S, Lappi J, Kosma VM.
    Anticancer Res; 2004 Dec 01; 24(4):2407-13. PubMed ID: 15330191
    [Abstract] [Full Text] [Related]

  • 39. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.
    Cancer; 2005 Jun 15; 103(12):2517-25. PubMed ID: 15880379
    [Abstract] [Full Text] [Related]

  • 40. Prognostic variables to predict cancer-related death in incidental renal tumours.
    Bensalah K, Pantuck AJ, Crepel M, Verhoest G, Méjean A, Valéri A, Ficarra V, Pfister C, Ferrière JM, Soulié M, Cindolo L, De La Taille A, Tostain J, Chautard D, Schips L, Zigeuner R, Abbou CC, Lobel B, Salomon L, Lechevallier E, Descotes JL, Guillé F, Colombel M, Belldegrun AS, Patard JJ.
    BJU Int; 2008 Nov 15; 102(10):1376-80. PubMed ID: 18727618
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.